Addus HomeCare Corp.

ADUS trades at a P/E of 19.35 despite operating in the fragmented home health care space where margins face persistent pressure from labor costs and reimbursement rates. The RSI of 58.8 suggests the stock is approaching overbought territory without yet reaching extremes, while the 5.93% short float indicates modest skepticism among bears. The stock's distance from its 52-week high raises questions about whether the valuation premium is sustainable given sector headwinds. At nearly 20x earnings, the market appears to be pricing in meaningful growth acceleration, leaving limited room for disappointment on guidance or utilization rates.